umbilical cord mesenchymal stem cells

Cell therapyexperimental

Clinical trial activity

369 trials · 267 clinical orgs · 0 marketing orgs

Phase 1
251
Phase 2
212
Phase 3
20
Phase 4
3

Earliest trial started Jan 1, 1999 (NCT00029380)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • LungTissue restoration

    Lung tissue restoration

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • allogeneic umbilical cord mesenchymal stem cells
  • allogeneitc umbilical cord mesenchymal stem cells
  • cartistem
  • dehydrated human umbilical cord allograft
  • furestem
  • human umbilical cord blood-derived mesenchymal stem cells
  • human umbilical cord derived mesencymal stem cells
  • human umbilical cord mesenchymal stem cells
  • human umbilical cord tissue-derived mesenchymal stromal cells
  • sangstat
  • umbilical cord blood mesenchymal stem cells
  • umbilical cord derived mesenchymal stem cells
  • umbilical cord-derived mesenchymal stem cells
  • umbilical cord mesenchymal stem cells
  • umbilical cord tissue-derived mesenchymal stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07075315Phase 3Jan 31, 2028Indian Council of Medical Research, Institute of Liver and Biliary Sciences, India
NCT07131306Phase 2Jan 31, 2027Indian Council of Medical Research, Institute of Liver and Biliary Sciences, India
NCT07144072Phase 1Jan 31, 2026Hexun Biosciences Co., LTD.
NCT07131540Phase 1Jan 31, 2026Indian Council of Medical Research, Institute of Liver and Biliary Sciences, India
NCT07304440N/AJan 15, 2026Adia Med of Winter Park LLC
NCT07313020Early Phase 1 (Phase 1)Dec 16, 2025Soochow University
NCT07232563Phase 1Dec 1, 2025Southern Medical University
NCT07137104Phase 1/Phase 2 (Phase 2)Dec 1, 2025Hexun Biosciences Co., LTD.
NCT07265349Phase 1/Phase 2 (Phase 2)Dec 1, 2025Tasly Pharmaceuticals, Inc.
NCT07160205Phase 2/Phase 3 (Phase 3)Nov 30, 2025Restem, LLC.
NCT07086521Phase 1Oct 31, 2025Restem, LLC.
NCT07058025Phase 2Oct 1, 2025Canadian Institutes of Health Research (CIHR), Stem Cell Network, University of Ottawa
NCT07175207Early Phase 1 (Phase 1)Oct 1, 2025Chinese Academy of Medical Sciences
NCT07177456Early Phase 1 (Phase 1)Oct 1, 2025Chinese Academy of Medical Sciences
NCT07197606Phase 2Oct 1, 2025IxCell Biotechnology
NCT06984497N/ASep 30, 2025People's Liberation Army of China
NCT07084012Phase 2Aug 27, 2025Capital Medical University, Government of China
NCT07041801Phase 1/Phase 2 (Phase 2)Jun 28, 2025Beike Biotech
NCT07011199Phase 1Jun 17, 2025Diponegoro University
NCT06954740Phase 2Jun 10, 2025People's Liberation Army of China
Showing 20 of 369 trials
Page 1 / 19

Organizations

Research & Development (267)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment443742009
Huazhong University of Science and TechnologyAcademic/Hospital231942018
Chinese Academy of Medical SciencesAcademic/Hospital191132012
Medipost Co Ltd.For profit141142008
Nanjing UniversityAcademic/Hospital14632010
Sclnow Biotechnology Co., Ltd.For profit141422017
Sun Yat-Sen UniversityAcademic/Hospital12732013
Duke UniversityAcademic/Hospital10921999
Prodia StemCell IndonesiaFor profit10922018
Beike BiotechFor profit9912009
Government of ChinaGovernment9642011
Jiao Tong UniversityAcademic/Hospital8232009
Kang Stem Biotech Co., Ltd.For profit8832013
University of IndonesiaAcademic/Hospital8552015
Qingdao UniversityAcademic/Hospital7722010
Sungkyunkwan UniversityAcademic/Hospital7432008
The Marcus FoundationAcademic/Hospital7032017
Translational BiosciencesFor profit7712013
Wuhan UniversityAcademic/Hospital7422020
Capital Medical UniversityAcademic/Hospital6222019
267 organizations
Page 1 / 14